CareDx Builds for the Future by Investing in Talent
SOUTH SAN FRANCISCO, Calif., March 31, 2021 (GLOBE NEWSWIRE) — CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the appointment of new senior leaders to create meaningful impact across key growth areas, build for the future, and enhance the patient journey.
“As we grow, we will continue to bring incredibly talented senior leaders to build the CareDx Village,” said Reg Seeto, President and Chief Executive Officer, CareDx. ”These recent hires and promotions reinforce our commitment to leadership in multi-modality innovation, places priority on patients first, enhances our integrated digital offerings, helps build new business, and creates a dedicated focus on our Villagers.”
CareDx is pleased to share the following new appointments, all designed to bring deep leadership experience to help guide growth and patient connection across all areas of transplantation—from pre-transplant products to post-transplant testing services.
In addition, Martyn Edney, has been appointed as Senior Vice President, Head of Human Resources. Martyn joins CareDx from IQVIA, where he was Vice President of Human Resources for the U.S. and Canada. Edney is a highly accomplished HR leader with a strong track record for leading transformational growth, focus, and accountability.
CareDx is also pleased to announce the promotion of the following two leaders who have made a significant impact on the organization.
About CareDx
CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.
CONTACTS:
CareDx, Inc.
Sasha King
Chief Marketing Officer
415-287-2393
sking@caredx.com
Investor Relations
Greg Chodaczek
347-610-7010
investor@caredx.com
GE HealthCare is helping advance clinical and operational excellence in theranostics and molecular imaging through…
RLT_Angels Photo RLT Angels Association Further founding members include the European Association of Nuclear Medicine…
From genomics to regulatory innovation, the Kingdom’s presence in Boston establishes it as a major…
Enzon and Viskase stockholders will respectively own approximately 15.9% and 84.1% of the combined companyCRANFORD,…
Higher dose of Wegovy® provided average weight loss of 21% in people with obesity –…
Subcutaneous amycretin phase 1b/2a data on the safety, tolerability and weight loss potential in people…